Showing 1 - 10 of 14
Persistent link: https://www.econbiz.de/10002195073
Persistent link: https://www.econbiz.de/10001658409
Persistent link: https://www.econbiz.de/10001781127
Persistent link: https://www.econbiz.de/10001534344
Persistent link: https://www.econbiz.de/10001465871
Persistent link: https://www.econbiz.de/10001271616
Persistent link: https://www.econbiz.de/10001027841
Persistent link: https://www.econbiz.de/10001333412
Persistent link: https://www.econbiz.de/10001228642
Criteria for initiation of highly active antiretroviral treatments (HAART) in HIV-infected patients remain a matter of debate world-wide because short-term benefits have to be balanced with costs of these therapies, and restrictions placed on future treatment options if resistant viral strains...
Persistent link: https://www.econbiz.de/10005100610